CASZ1 and hepatocellular carcinoma: Indeed, the results of 10-Pathway Reporter Array in CASZ1-interfered HCC cells showed that CASZ1 could significantly inhibited the activity of MAPK/ERK signaling, which was further confirmed by western blot and IHC assays.